Fibrinogen (Prothrombin Fragment PP) Coagulation Assay

What This Test Measures

Fibrinogen is a protein that plays a critical role in blood clotting. When blood clots form, fibrinogen is converted into fibrin, which helps stabilize the clot. This test specifically looks at a specific fragment (Prothrombin Fragment PP) generated during this process. Measuring these fragments can provide insights into how efficiently your blood is clotting and whether clotting is occurring normally or prematurely.

Why It Might Be Ordered

Your healthcare provider may order this test if you have symptoms or conditions related to abnormal clotting, such as bleeding disorders, clotting disorders, or if you are undergoing treatments that affect blood clotting (e.g., anticoagulants). It may also be used to monitor certain medical conditions or to assess the effectiveness of treatments aimed at blood clotting.

Common Conditions or Situations

This test is often used in scenarios where there is suspicion of altered fibrin formation, such as in patients with bleeding disorders (e.g., hemophilia), those receiving anticoagulant medications, or individuals with conditions affecting blood vessel integrity. It can also be part of a broader evaluation for conditions like disseminated intravascular coagulation (DIC).

Sample Collection and Preparation

This test typically uses a sample of whole blood collected in a special tube that prevents clotting. The blood is processed to separate the plasma, where the fibrinogen fragments are measured. The test may be performed on fresh or stored samples, depending on laboratory protocols.